Article Text
Abstract
Objectives: Human herpesvirus 8 (HHV-8) infection is common among men who have sex with men (MSM), especially those infected with HIV, and is frequently detected in saliva. We sought to determine whether oral or anogenital contact with HIV discordant, or unknown serostatus sexual partners is associated with HHV-8 seroprevalence among HIV negative MSM.
Methods: HIV negative MSM participating in a behavioural intervention trial for the prevention of HIV infection (the EXPLORE study) were recruited from the Seattle and Denver areas for participation in this cross sectional study. Participants completed detailed questionnaires regarding sexual behaviour, focusing on activities with possible exposure to the oropharynx. Serum samples from study enrolment were tested for the presence of HHV-8 antibodies using whole virus enzyme immunoassay and immunofluorescence assay to latent and lytic proteins.
Results: 198/819 MSM (24.3%) were HHV-8 antibody positive. Exposure to saliva with HIV positive and HIV unknown serostatus sex partners was reported by 83% and 90% of all men, respectively. In a multivariate model, reporting more than the median number of lifetime sex partners (OR 2.2, p = 0.03) or lifetime sex partners of unknown HIV status (OR 1.7, p = 0.03), and the performance of oro-anal sex (“rimming”) on partners whose HIV status is unknown (OR 2.7, p = 0.04) were independently associated with HHV-8 infection.
Conclusions: The oropharynx may be an important anatomical site in HHV-8 acquisition, and contact with HIV serodiscordant or unknown sex partners is associated with higher HHV-8 seroprevalence among HIV negative MSM.
- EIA, enzyme immunoassay
- GEE, generalised estimating equations
- HHV-8, human herpesvirus 8
- IFA, immunofluorescence assay
- IQR, interquartile range
- KS, Kaposi sarcoma
- MSM, men who have sex with men
- human herpesvirus
- saliva
- oropharynx
Statistics from Altmetric.com
Footnotes
-
Financial support: NIH grants P01 AI30731, U19 AI31448, and K23 AI054162, and the Joel Meyers Infectious Disease Scholarship Grant.